Alere Inc., formerly known as Inverness Medical Innovations, is a company that specializes in diagnostics and health management solutions. It focuses on infectious disease, cardiology, oncology, drugs of abuse, and women's health, offering a wide array of products and services. Alere's portfolio includes over-the-counter tests, lab-based diagnostics, and integrated home monitoring solutions, with notable brands such as Acceava Mono cassette, Alere Home Monitoring, AtheNA Multi-Lyte Test System, and BinaxNOW. The company operates across multiple regions, including North America, Europe, the Middle East, Asia Pacific, and Latin America and Africa. Its medical diagnostic products aim to facilitate the detection of diseases and conditions, empowering patients and healthcare providers to collaboratively manage health outcomes throughout the continuum of care from hospitals to home settings.
Epocal develops and provides a point of care blood diagnostic systems for healthcare enterprises. The company has produced epoc, a wireless bedside blood testing solution that provides lab results directly to a hand-held mobile computer. Epocal offers its products for hospitals, physicians’ offices, and patients’ homes. The company was founded in 2001 and is based in Ottawa, Canada.
eScreen
Acquisition in 2012
eScreen, Inc. specializes in developing, manufacturing, and marketing employment screening products, primarily focused on drug testing solutions. The company provides a range of innovative products and software designed to streamline and automate the hiring process for employers, donors, and clinics. Notable offerings include the eScreen device, which is an instrumented point-of-collection testing system, and eScreen123, a software solution tailored for occupational health providers. The company also features MyeScreen.com, an online platform for program management and result reporting, as well as MRO Software for verification management. Additional products include the eScreen eCup, a self-contained testing device, the eScreen eReader for digital collections, and mCup and mCheck, which are manual drug testing devices. eScreen also provides web-based services that deliver real-time drug test data, enhancing the efficiency of the screening process. Founded in 1998, eScreen is headquartered in Overland Park, Kansas.
Arriva Medical
Acquisition in 2011
Arriva Medical specializes in supplying diabetic testing products, focusing on enhancing the diabetes management experience for patients. The company offers a range of testing supplies, including advanced talking meters and element meters designed to facilitate accurate monitoring of blood glucose levels. By providing these essential tools, Arriva Medical aims to support individuals with diabetes in managing their condition effectively and improving their overall health outcomes.
RMD Networks
Acquisition in 2010
RMD Networks specializes in appointment scheduling services that facilitate communication between doctors and patients. The company offers a comprehensive platform that allows users to schedule appointments, request medication refills, and manage referrals. Additionally, RMD Networks provides tools for users to create and maintain personal health records, address insurance and billing inquiries, and communicate effectively with their healthcare providers. This range of services aims to enhance the overall healthcare experience for patients while streamlining administrative tasks for medical professionals.
Free & Clear
Acquisition in 2009
Free & Clear, Inc. specializes in phone-based tobacco treatment services aimed at employers, health plans, and government agencies. The company provides a comprehensive tobacco cessation program, known as the Quit For Life Program, which assists employees and members of private organizations in quitting smoking and using smokeless tobacco. Additionally, Free & Clear offers the Mind & Body Program, a behavioral change initiative designed to promote healthy weight management and address health risks associated with chronic diseases, such as tobacco use, poor nutrition, and physical inactivity. By delivering these clinically proven solutions, Free & Clear aims to support individuals in achieving healthier lifestyles.
Redwood Toxicology Laboratory
Acquisition in 2007
Redwood Toxicology Laboratories provides extensive drug and alcohol monitoring as well as laboratory facilities at a low cost.
Biosite Incorporated
Acquisition in 2007
Biosite Incorporated provides diagnostic products and antibody development technologies for sever diseases. It provides seversl products such as Triage drug of abuse panel, a point-of-care diagnostic test for detecting overdosed prescription and illicit drugs; Triage TOX Drug Screen, a fluorescence immunoassay to detect abused drugs; Triage cardiac panel, a diagnosis aid for heart attack; and Triage BNP test, a diagnosis and assessment aid for the heart failure; and other products. It also provides Triage D-dimer test, an immunoassay for use as an aid in the assessment and evaluation of patients having disseminated intravascular coagulation or thromboembolic events. Furthermore, it offers medical education, technical service and support, and consulting services. Biosite Incorporated distributes its products through distributors in the United States and internationally. It was established in 1988 and is based in San Diego, California with sales offices in Switzerland, the Asia Pacific, the Netherlands, France, Germany, Italy, Spain, and the United Kingdom. Currently it operates as a subsidiary of Alere Inc.
Quality Assured Services
Acquisition in 2007
Quality Assured Services is a privately held provider of diagnostic home tests and services.
Cholestech
Acquisition in 2007
Cholestech specializes in point-of-care diagnostics solutions focused on chronic diseases. Founded in 1988 and headquartered in San Diego, California, the company is well-known for its flagship product, the Cholestech LDX system, which measures cholesterol, glucose, liver enzymes, and C-reactive protein to help identify patients at high risk for heart disease. Additionally, Cholestech offers the GDX system for A1C testing. In 2007, the company was acquired by Alere for $326.3 million, further solidifying its presence in the healthcare market.
Instant Technologies
Acquisition in 2007
Instant Technologies is a prominent manufacturer and supplier of on-site rapid test devices. The company specializes in various testing solutions, including drug and alcohol testing, women's health screenings, and clinical diagnostics. By focusing on the development and provision of these rapid testing devices, Instant Technologies aims to enhance accessibility and efficiency in health-related assessments.
CLONDIAG chip technologies
Acquisition in 2006
CLONDIAG chip technologies is a company which has developed a multiplexing technology for nucleic acid and immunoassay based diagnostics.
Ischemia Technologies
Acquisition in 2005
Ischemia Technologies is a Denver-based company that specializes in diagnostic tests for cardiovascular and acute care medicine. It develops, manufactures, and markets in vitro diagnostic products focused on cardiac ischemia, a condition characterized by insufficient blood supply to the heart resulting from the obstruction of a coronary artery. The company's diagnostic devices are designed to assist medical professionals in addressing acute clinical situations that require prompt and accurate diagnosis.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.